Clinical Trial Update: ASCT With Nivolumab in Patients With Multiple Myeloma [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports a Phase 1/2 study evaluating autologous stem cell transplantation augmented with nivolumab in patients with multiple myeloma.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• OPDIVO (nivolumab)

Snippet

Sponsor: St. Petersburg State Pavlov Medical University | Conditions: Multiple Myeloma | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING